CIK 0001601830
- Large accelerated filer
RECURSION PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RXRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464099738
- Phone
- +1 385-269-0203
- Business address
- 41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
- Former names
- Recursion Pharmaceuticals, LLC
- 4 Grant or award Director acquired 88,424 shares (grant or award)
- 4 Grant or award Director acquired 88,424 shares (grant or award)
- 4 Grant or award Director acquired 88,424 shares (grant or award)
- 4 Grant or award Director acquired 88,424 shares (grant or award)
- 4 Grant or award Director acquired 88,424 shares (grant or award)
- 4 Grant or award Director acquired 88,424 shares (grant or award)
- 4 Planned sale Director sold 3,963 shares at $3.18 ($12,602)
- 4 Shares withheld for taxes Chief Financial Officer gave up 5,396 shares (to pay taxes)
- 4 Planned sale Director sold 40,000 shares at $3.62 ($144,800)
- 4 Planned sale CEO and President sold 23,588 shares at $3.58 ($84,459)
- 4 Planned sale Director sold 4,386 shares at $3.54 ($15,526)
- 4 Planned sale Director sold 30,000 shares at $3.68 ($110,400)
- 4 Planned sale Director sold 40,000 shares at $3.08 ($123,200)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 26,657 shares (to pay taxes)
- 4 Shares withheld for taxes CEO and President gave up 62,701 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 25,018 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 22,821 shares (to pay taxes)
- 4 Planned sale Director sold 40,000 shares at $3.37 ($134,800)
- 4 Planned sale Director sold 30,000 shares at $3.52 ($105,600)
- 4 Planned sale Director sold 40,000 shares at $3.61 ($144,400)
Page 2 of 26 · 512 filings